Abstract:In the past decade, the study of mechanisms of cancer immunity has seen a prominent boom, which paralleled the increased amount of research on the clinical efficacy of immune checkpoint blockade in several lethal types of cancers. This conspicuous effort has led to the development of successful immunotherapy treatment strategies, whose medical impact has been recognized by the awarding of 2018 Nobel Prize in Physiology or Medicine to the two pioneers of check point inhibitor research, Tasuku Honjo and James Allison. Despite these promising achievements, the differences in the clinical response rate in different cancer patients and the high risk of toxicity of immune-based therapies represent crucial challenges. More remarkably, the causes responsible for different outcome (success vs failure) in patients with tumor having same histotype and clinical characteristics remain mostly unknown. MicroRNAs (miRNAs), small regulatory noncoding RNA molecules representing the most studied component of the dark matter of the human genome, are involved in the regulation of many pathways of cancer and immune cells. Therefore, understanding the role of miRNAs in controlling cancer immunity is necessary, as it can contribute to reveal mechanisms that can be modulated to improve the success of immunetherapy in cancer patients. Here, we discuss the latest findings on immune pathways regulated by miRNAs in cancer, miRNA-mediated regulation of immune cells in the tumor microenvironment, and miRNAs as potential target for immunotherapies.

MicroRNAs: immune modulators in cancer immunotherapy

Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

Function of Microrna-145 and Mechanisms Underlying Its Role in Malignant Tumor Diagnosis and Treatment

Regulation of tumor immunity by microRNAs

MicroRNAs Involved in Anti-Tumour Immunity

Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy

Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression

Role of miRNAs in immune responses and immunotherapy in cancer

miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma

Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade

MicroRNAs: Novel Immunotherapeutic Targets in Colorectal Carcinoma.

The role of cancer-derived microRNAs in cancer immune escape

MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

miRNA-based biomarkers, therapies, and resistance in Cancer

MiRNAs in Cancer Therapy: Focusing on Their Bi-Directional Roles

How MicroRNAs Command the Battle against Cancer

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors

MicroRNAs and Cancer: Key Paradigms in Molecular Therapy (Review)

Potential Regulatory Roles of MicroRNAs and Long Noncoding RNAs in Anticancer Therapies

Potential Microrna Targets For Cancer Chemotherapy

Role of microRNAs in Immune Regulation with Translational and Clinical Applications